The morbidity, disability, and mortality associated with respiratory diseases in the Russian Federation (2015 – 2019)
https://doi.org/10.18093/0869-0189-2021-31-5-551-561
Abstract
Respiratory diseases (RD) represent one of the most urgent issues in Russian health care and have high socio-economic significance.
The aim. To study the dynamics of total morbidity and mortality in the Russian Federation, as well as the mortality associated with RD in the working-age population in 2015 – 2019.
Methods. The official statistical data of the Ministry of Health of the Russian Federation and the Federal State Statistics Service were analyzed.
Results. In 2019, the total RD-associated morbidity increased by 5.4%, and the prevalence of pneumonia increased by 29.0% compared to 2015. In 5 federal districts (FD), the morbidity exceeded the average Russian morbidity in 2019 (40,694.7). The maximum level was observed in the North-Western FD (50,224.1). The prevalence of pneumonia (Russia – 524.4) in 4 FDs exceeded the average Russian prevalence. The maximum level was reported in the Far Eastern FD (749.2 cases per 100 thousand of the total population). The RD-associated mortality rate in Russia was 51.8 cases per 100 thousand in 2015 and 41.6 cases per 100 thousand in 2018 (–19.7%). In 2018, the highest RD-associated mortality was observed in the Siberian FD (68.0) and Far Eastern FD (57.8 per 100 thousand people). From January to December 2019, the highest mortality associated with pneumonia in the working-age population was observed in the Far Eastern FD (28.2 per 100 thousand people). The RD-associated mortality rate in the male population was 4.2 times higher than in the female population (26.7 and 6.3, respectively, per 100 thousand persons of matching age).
Conclusion. The highest morbidity was found in 2018 and 2019 in the Northwestern FD and Far Eastern FD. The RD-associated mortality in the Siberian FD and Far Eastern FD exceeded the average Russian values. This last observation requires additional research to improve the quality of medical care.
About the Authors
Elena V. Bystritskaya
Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia
Russian Federation
Competing Interests:
Russian Federation
Elena V. Bystritskaya, Candidate of Medicine, Leading Researcher, Laboratory of Clinical Epidemiology
SPIN: 8706-3280
Orekhovyy bul’var 28, Moscow, 115682
tel.: (964) 631-70-79
Competing Interests:
The authors declare no conflict of interest
Tatiana N. Bilichenko
Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia
Russian Federation
Competing Interests:
Russian Federation
Tatiana N. Bilichenko, Doctor of Medicine, Professor, Head of Laboratory of Clinical Epidemiology
SPIN: 4671-0084
Orekhovyy bul’var 28, Moscow, 115682
tel.: (495) 965-11-15
Competing Interests:
The authors declare no conflict of interest
References
1. Ivanova E.V., Bilichenko T.N., Chuchalin A.G. [Morbidity and mortality from respiratory diseases in employable population of Russia in 2010 – 2012]. Pul'monologiya. 2015; 25 (3): 291–297. DOI: 10.18093/0869-0189-2015-25-3-291-297 (in Russian).
2. Federal Service for Supervision of Consumer Rights Protection and Human Welfare. [On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2017: State report]. 2018. Available at: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=10145 (in Russian).
3. World Health Organization. [WHO European guidelines for human influenza surveillance]. 2019. Available at: http://mail.57.rospotrebnadzor.ru:81/gripp/rukovodstvo-voz-po-epidnadzoru-za-grippom.pdf (in Russian).
4. World Health Organization. Influenza virus infections in humans (February 2014). Available at: https://www.who.int/influenza/human_animal_interface/virology_laboratories_and_vaccines/influenza_virus_infections_humans_feb14.pdf
5. World Health Organization. [WHO Regional Office for Europe guidelines for influenza vaccination in the 2017 – 2018 winter season]. September 2017. Available at: https://www.euro.who.int/__data/assets/pdf_file/0011/349868/Influenza-vaccine-recommendations-2017-2018_13_sep_2017_RU.pdf (in Russian).
6. Gruzdeva O.A., Bilichenko T.N., Baryshev M.A., Zhukova A.V. [The impact of vaccination against influenza and pneumococcal infection on the incidence of acute respiratory viral infections and community-acquired pneumonia in the Central Administrative District of Moscow]. Epidemiologiya i vaktsinoprofilaktika. 2021; 20 (2): 28–41. DOI: 10.31631/2073-3046-2021-20-2-28-41 (in Russian).
7. Bilichenko T.N., Bystritskaya E.V., Chuchalin A.G. et al. [Mortality of respiratory disease in 2014 – 2015 and ways of its improvement]. Pul'monologiya. 2016; 26 (4): 389–397. DOI: 10.18093/0869-0189-2016-26-4-389-397 (in Russian).
8. World Health Organization. GATS Russian Federation. Global Adult Tobacco Survey: Country report 2016. Available at: https://www.euro.who.int/__data/assets/pdf_file/0010/392887/gats-rus-rep-eng.pdf
Review
For citations:
Bystritskaya E.V., Bilichenko T.N. The morbidity, disability, and mortality associated with respiratory diseases in the Russian Federation (2015 – 2019). PULMONOLOGIYA. 2021;31(5):551-561. (In Russ.) https://doi.org/10.18093/0869-0189-2021-31-5-551-561
Views:
2350
Email this article 